Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Ege David S.. Officer active across 1 company, notably Seres Therapeutics, Inc.. In total, 7 disclosures have been recorded. Activity tracked since 5 July 2022. The latest transaction was disclosed on 27 October 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Ege David S. is a declarant linked to Seres Therapeutics, Inc. (XNAS), with the role listed as “See Remarks” for that company. The record shows 7 filings in total, and among the sampled recent filings the period runs from 2022-07-06 to 2024-08-19, with the transaction nature listed as “Levée d'options”.